FLASH Radiotherapy Maintains Systemic and Tissue Balance While Effectively Targeting Tumors - Summary - MDSpire

FLASH Radiotherapy Maintains Systemic and Tissue Balance While Effectively Targeting Tumors

  • By

  • Giulia Furini

  • Eduarda Mota da Silva

  • Alice Usai

  • Gaia Scabia

  • Claudia Kusmic

  • Francesco Faita

  • Andrea Cavalieri

  • Mariagrazia Celentano

  • Mario Costa

  • Filippo Rossi

  • Giulia Asero

  • Roberta Di Pietro

  • Emanuela Guerra

  • Stefano Lattanzio

  • Tonia Luca

  • Sergio Castorina

  • Roberto Cusano

  • Riccardo Berutti

  • Jessica Milia

  • Simone Capaccioli

  • Alessandra Gonnelli

  • Noemi Giannini

  • Fabiola Paiar

  • Saverio Cinti

  • Fabio Di Martino

  • Margherita Maffei

  • February 26, 2026

  • 0 min

Share

Objective:

To compare the effects of electron FLASH-RT and CONV-RT on tumor control, normal tissue responses, and systemic effects in a syngeneic melanoma model, emphasizing the comparative aspect.

Key Findings:
  • FLASH-RT spares normal tissues while maintaining tumor control, particularly in melanoma, with significant transcriptomic changes indicating long-term effects.
  • Systemic effects of FLASH-RT include changes in body weight dynamics and metabolic parameters.
  • Transcriptomic changes in healthy tissues indicate long-term effects of FLASH-RT not previously reported.
Interpretation:

FLASH-RT shows promise in reducing normal tissue toxicity while effectively targeting tumors, with potential systemic benefits that warrant further investigation and implications for future research.

Limitations:
  • Limited generalizability due to small number of tumor types and specific mouse models used, highlighting the need for more diverse tumor models.
  • Mechanisms underlying the FLASH effect remain poorly understood.
Conclusion:

FLASH-RT represents a novel approach in radiotherapy that could improve patient outcomes by minimizing adverse effects while effectively treating tumors, particularly in radio-resistant cancers like melanoma, with significant clinical applications.

Original Source(s)

FLASH Radiotherapy Maintains Systemic and Tissue Balance While Effectively Targeting Tumors

  • by Giulia Furini, Eduarda Mota da Silva, Alice Usai, Gaia Scabia, Claudia Kusmic, Francesco Faita, Andrea Cavalieri, Mariagrazia Celentano, Mario Costa, Filippo Rossi, Giulia Asero, Roberta Di Pietro, Emanuela Guerra, Stefano Lattanzio, Tonia Luca, Sergio Castorina, Roberto Cusano, Riccardo Berutti, Jessica Milia, Simone Capaccioli, Alessandra Gonnelli, Noemi Giannini, Fabiola Paiar, Saverio Cinti, Fabio Di Martino, Margherita Maffei

  • February 26, 2026

Related Content

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?